Browse
Collections
Compounds grouped by family and type. Each collection is built automatically from the guide's data.
Educational only. A summary of published research, not medical advice or a recommendation. No doses are listed.
-
GLP-1 compounds
4 compounds
Medicines and investigational drugs that activate the GLP-1 receptor, alone or together with the GIP or glucagon receptors.
Semaglutide, Tirzepatide, Retatrutide, Survodutide
-
Amylin compounds
1 compound
Compounds that mimic amylin, a fullness hormone released together with insulin.
Cagrilintide
-
GH secretagogues
4 compounds
Peptides that make the pituitary gland release more of the body's own growth hormone.
Tesamorelin, Sermorelin, CJC-1295, Ipamorelin
-
Tissue repair peptides
3 compounds
Peptides studied for healing of tendons, skin, muscle and the gut, mostly in animal and lab studies.
BPC-157, TB-500, GHK-Cu
-
Nootropics
2 compounds
Peptides studied for effects on the brain, such as focus, memory and anxiety.
Selank, Semax
-
Bioregulators
1 compound
Short peptides from the Russian “peptide bioregulator” research tradition, modeled on extracts of glands.
Epitalon
-
Anabolics
12 compounds
Anabolic-androgenic steroids: testosterone and drugs made from it, all acting on the androgen receptor.
Testosterone, Nandrolone, Trenbolone, Boldenone +8 more
-
DHT derivatives
6 compounds
Steroids built on dihydrotestosterone (DHT). They can't be converted to estrogen.
Oxandrolone, Oxymetholone, Stanozolol, Drostanolone +2 more
-
19-nors
2 compounds
“19-nor” steroids, which lack one carbon atom of testosterone. They also act on progesterone receptors.
Nandrolone, Trenbolone
-
Oral anabolics
7 compounds
Steroids taken as tablets. Most are chemically modified (17α-alkylated) to survive the liver, which is why many are hard on it.
Methandrostenolone, Oxandrolone, Oxymetholone, Stanozolol +3 more
-
Fat loss compounds
8 compounds
Compounds approved, in trials or studied for fat or weight loss. The same list as the Fat loss effect page.
Semaglutide, Tirzepatide, Retatrutide, Survodutide +4 more
-
Emerging research compounds
3 compounds
Compounds in clinical trials that aren't approved yet.
Retatrutide, Survodutide, Cagrilintide